Elotuzumab for Treatment of Multiple Myeloma (Literature Review)
Chemotherapy has been the main treatment option for multiple myeloma for several decades. However, a considerable increase in the life expectancy was observed in multiple myeloma patients when thalidomide, bortezomib and lenalidomide had been introduced into clinical practice. Nevertheless, the dise...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Russo |
| Publicat: |
Practical Medicine Publishing House
2016-10-01
|
| Col·lecció: | Клиническая онкогематология |
| Matèries: | |
| Accés en línia: | https://bloodjournal.ru/index.php/coh/article/view/513 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|